The main interest of our research group is the medicinal chemisq of agonists and antagonists of the neurotransmitters dopamine (DA) and serotonine (5-HT) and their modes of pharmacological interaction with dopaminergic and serotonergic neurotransmitter systems in the brain. The group is currently interested in the rational design, synthesis and pharmacological evaluation of new dopaminergic and serotonergic agents with clinical potential. Dopamine is an important neurotransmitter in the brain and is known to play an important role in Parkinson's disease, schizophrenia, and possibly depression. Serotonine is thought to be involved in various functions such as anxiety, aggression, depression, stress, sexual behaviour, and body temperature
Through its projections to various brain areas, serotonin participates to the control of numerous fu...
The research described in this thesis is divided into two parts. Part I (chapters 1-3) deals with th...
In order to explore further the structure-activity relationships of serotonergic and dopaminergic li...
The main interest of our research group is the medicinal chemisq of agonists and antagonists of the ...
The use of dopaminergic agonists is key in the treatment of Parkinson's disease and related central ...
The main interest of our research group is the medicinal chemisq of agonists and antagonists of the ...
A new chemical class of potential atypical antypsychotic agents, based on the pharmacological concep...
A new chemical class of potential atypical antypsychotic agents, based on the pharmacological concep...
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the a...
It is known since the 1950s that enhancement of the levels of the monoamines dopamine (DA), serotoni...
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders
Serotonin (5HT) is a monoamine neurotransmitter that modulates a wide range of brain functions via t...
A review. Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, d...
A brief review of dopamine and serotonin pharmacology is presented as well as discussion of the desi...
The serotonin 2B receptor (5-HT2BR) is the most recent addition to the 5-HT2R family. During the las...
Through its projections to various brain areas, serotonin participates to the control of numerous fu...
The research described in this thesis is divided into two parts. Part I (chapters 1-3) deals with th...
In order to explore further the structure-activity relationships of serotonergic and dopaminergic li...
The main interest of our research group is the medicinal chemisq of agonists and antagonists of the ...
The use of dopaminergic agonists is key in the treatment of Parkinson's disease and related central ...
The main interest of our research group is the medicinal chemisq of agonists and antagonists of the ...
A new chemical class of potential atypical antypsychotic agents, based on the pharmacological concep...
A new chemical class of potential atypical antypsychotic agents, based on the pharmacological concep...
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the a...
It is known since the 1950s that enhancement of the levels of the monoamines dopamine (DA), serotoni...
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders
Serotonin (5HT) is a monoamine neurotransmitter that modulates a wide range of brain functions via t...
A review. Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, d...
A brief review of dopamine and serotonin pharmacology is presented as well as discussion of the desi...
The serotonin 2B receptor (5-HT2BR) is the most recent addition to the 5-HT2R family. During the las...
Through its projections to various brain areas, serotonin participates to the control of numerous fu...
The research described in this thesis is divided into two parts. Part I (chapters 1-3) deals with th...
In order to explore further the structure-activity relationships of serotonergic and dopaminergic li...